Focal segmental glomerulosclerosis after renal transplantation

Clinical Transplantation

Volumn 25, Issue SUPPL. 23, 2011, Pages 6-14

  Shimizu, Akira ^a   Higo, Seiichiro ^a   Fujita, Emiko ^b   Mii, Akiko ^b   Kaneko, Tomohiro ^b  

^a Department of Pathology ^*  (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

COLOMBIA; DISEASE CLASSIFICATION; DRUG MEGADOSE; FOCAL GLOMERULOSCLEROSIS; HISTORICAL RESEARCH; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW;

GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION;

EID: 79957609478     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01452.x     Document Type: Review

References (90)

1. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004: 43: 368.
2. D'Agati VD, Jennette JC, Silva FG. Focal segmental glomerulosclerosis. In: D'Agati VD, Jennette JC, Silva FG eds. Atras of Nontumor Pathology, Non-Neoplastic Kidney Disease. Washington, DC: American Registry of Pathology Press, 2005: 125.
3. Schwartz MM. Focal segmental Glomerulosclerosis. In: Jennette JC, Olson JL, Schwarts MM, Silva FG, eds, Heptinstall's Pathology of the Kidney, 6th edn. Philadelphia/Baltinore: Lippincott Williams &Wilkins, 2007: 155.
4. McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010: 5: 2115.
5. D'Agati VD, Jennette JC, Silva FG. Pathology of renal transplantation. In: D'Agati VD, Jennette JC, Silva FG eds. Atras of Nontumor Pathology, Non-Neoplastic Kidney Disease. Washington, DC: American Registry of Pathology Press, 2005: 667.
6. Colvin RB, Nickeleit V. Renal transplant pathology. In: Jennette JC, Olson JL, Schwarts MM, Silva FG eds. Heptinstall's Pathology of the Kidney, 6th edn. Philadelphia/Baltinore: Lippincott Williams &Wilkins, 2007: 1347.
7. Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992: 92: 375.
8. Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999: 14: 2650.
9. Pardon A, Audard V, Caillard S et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006: 21: 1053.
10. Vincenti F, Ghiggeri GM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005: 5: 1179.
11. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006: 6: 2535.
12. Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010: 5: 2363.
13. Cosio FG, Frankel WL, Pelletier RP, Pesavento TE, Henry ML, Ferguson RM. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival. Am J Kidney Dis 1999: 34: 731.
14. Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999: 68: 635.
15. Lvanyi B. A primer on recurrent and de novo glomerulonephritis in renal allografts. Nat Clin Pract Nephrol 2008: 4: 446.
16. Takeda A, Morozumi K, Koyama K et al. Severe cyclosporine arteriolopathy with focal segmental glomerulosclerosis is not a fatal finding in chronic renal allograft failure after year 5 of transplantation using cyclosporine. Transplant Proc 1997: 29: 96.
17. Tada M, Jimi S, Hisano S et al. Histopathological evidence of poor prognosis in patients with vesicoureteral reflux. Pediatr Nephrol 2001: 16: 482.
18. Rich AR. A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 1957: 100: 173.
19. Churg J, Habib R, White RH. Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet 1970: 760: 1299.
20. Habib R. Focal glomerular sclerosis. Kidney Int 1973: 4: 355.
21. Brown CB, Cameron JS, Turner DR et al. Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS"). Clin Nephrol 1978: 10: 51.
22. Howie AJ, Brewer DB. The glomerular tip lesion: a previously undescribed type of segmental glomerular abnormality. J Pathol 1984: 142: 205.
23. Schwartz MM, Lewis EJ. Focal segmental glomerular sclerosis: the cellular lesion. Kidney Int 1985: 28: 968.
24. Weiss MA, Daquioag E, Margolin EG, Pollak VE. Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity? Am J Kidney Dis 1986: 7: 20.
25. Rao TK, Fillippone EJ, Nicastri AD et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984: 310: 669.
26. Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989: 13: 443.
27. D'Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994: 46: 1223.
28. Thomas DB, Franceschini N, Hogan SL et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006: 69: 920.
29. Thomas DB. Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution. Arch Pathol Lab Med 2009: 133: 217.
30. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992: 2(12 Suppl): S258.
31. Abbott KC, Sawyers ES, Oliver JD III et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001: 37: 366.
32. Cibrik DM, Kaplan B, Campbell DA, Meier-Kriesche HU. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 2003: 3: 64.
33. Chadban S. Glomerulonephritis recurrence in the renal graft. J Am Soc Nephrol 2001: 12: 394.
34. Crosson JT. Focal segmental glomerulosclerosis and renal transplantation. Transplant Proc 2007: 39: 737.
35. Swaminathan S, Lager DJ, Qian X, Stegall MD, Larson TS, Griffin MD. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant 2006: 21: 2607.
36. IJpelaar DH, Farris AB, Goemaere N et al. Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol 2008: 19: 2219.
37. Canaud G, Dion D, Zuber J et al. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 2010: 25: 1321.
38. Weber S, Tönshoff B. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects. Transplantation 2005: 80(1 Suppl): S128.
39. Bertelli R, Ginevri F, Caridi G et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003: 41: 1314.
40. Verani RR, Hawkins EP. Recurrent focal segmental glomerulosclerosis. A pathological study of the early lesion. Am J Nephrol 1986: 6: 263.
41. Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ. Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis. Ren Fail 2008: 30: 477.
42. Deegens JK, Dijkman HB, Weening JJ et al. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 2008: 74: 1568.
43. Schwartz MM. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis. Ren Fail 2000: 22: 663.
44. Barisoni L, Mundel P. Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 2003: 23: 353.
45. Meyrier A. Mechanisms of Disease: focal segmental glomerulosclerosis. Nat Clin Pract Nephrol 2005: 1: 44.
46. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007: 71: 1205.
47. D'Agati VD. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int 2008: 73: 399.
48. Barisoni L, Schnaper HW, Kopp JB. Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med 2009: 133: 201.
49. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 2006: 69: 2131.
50. Mundel P, Reiser J. Proteinuria: an enzymatic disease of the podocyte? Kidney Int 2010: 77: 571.
51. Mathieson PW. Podocyte actin in health, disease and treatment. Nephrol Dial Transplant 2010: 25: 1772.
52. Kemeny E, Mihatsch MJ, Dürmüller U, Gudat F. Podocytes loose their adhesive phenotype in FSGS. Clin Nephrol 1995: 43: 71.
53. Nakamura T, Ushiyama C, Suzuki S et al. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. Am J Nephrol 2000: 20: 175.
54. Hara M, Yanagihara T, Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 2001: 89: 342.
55. Kanno K, Kawachi H, Uchida Y, Hara M, Shimizu F, Uchiyama M. Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract 2003: 95: c91.
56. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005: 16: 1733.
57. Hara M, Yanagihara T, Hirayama Y et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol 2010: 41: 1265.
58. Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005: 16: 2257.
59. Suzuki T, Matsusaka T, Nakayama M et al. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Am J Pathol 2009: 174: 1675.
60. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int 2000: 58: 674.
61. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 2000: 58: 137.
62. Marshall CB, Shankland SJ. Cell cycle regulatory proteins in podocyte health and disease. Nephron Exp Nephrol. 2007: 106: e51.
63. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999: 10: 51.
64. Bariéty J, Bruneval P, Hill G et al. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001: 12: 261.
65. Ohtaka A, Ootaka T, Sato H, Ito S. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm? Nephrol Dial Transplant 2002: 17(Suppl 9): 11.
66. Bariéty J, Bruneval P, Hill GS et al. Transdifferentiation of epithelial glomerular cells. J Am Soc Nephrol 2003: 14(Suppl 1): S42.
67. Ohse T, Pippin JW, Chang AM et al. The enigmatic parietal epithelial cell is finally getting noticed: a review. Kidney Int 2009: 76: 1225.
68. Nagata M, Hattori M, Hamano Y et al. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy. Am J Kidney Dis 1998: 32: 962.
69. Nagata M, Horita S, Shu Y et al. Phenotypic characteristics and cyclin-dependent kinase inhibitors repression in hyperplastic epithelial pathology in idiopathic focal segmental glomerulosclerosis. Lab Invest 2000: 80: 869.
70. Smeets B, Te Loeke NA, Dijkman HB et al. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol 2004: 15: 928.
71. Bariéty J, Bruneval P, Hill G, Irinopoulou T, Mandet C, Meyrier A. Posttransplantation relapse of FSGS is characterized by glomerular epithelial cell transdifferentiation. J Am Soc Nephrol 2001: 12: 261.
72. Smeets B, Dijkman HB, Wetzels JF, Steenbergen EJ. Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells? J Pathol 2006: 210: 663.
73. Ma LJ, Fogo AB. Modulation of glomerulosclerosis. Semin Immunopathol 2007: 29: 385.
74. Bhathena DB. Glomerular size and the association of focal glomerulosclerosis in long-surviving human renal allografts. J Am Soc Nephrol 1993: 4: 1316.
75. Bosch T, Wendler T. Extracorporeal plasma treatment in primary and recurrent focal segmental glomerular sclerosis: a review. Ther Apher 2001: 5: 155.
76. Deegens JKJ, Andresdottir MB, Croockewit S, Wetzels JFM. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplantation. Transpl Int 2004: 17: 151.
77. Meyrier AY. Treatment of focal segmental glomerulosclerosis with immunophilin modulation: when did we stop thinking about pathogenesis? Kidney Int 2009: 76: 487.
78. Canaud G, Martinez F, Noël LH, Mamzer MF, Niaudet P, Legendre C. Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev (Orlando) 2010: 24: 121.
79. Faul C, Donnelly M, Merscher-Gomez S et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008: 14: 931.
80. Mathieson PW. Proteinuria and immunity - an overstated relationship? N Engl J Med 2008: 359: 2492.
81. Odorico JS, Knechtle SJ, Rayhill SC et al. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996: 61: 228.
82. Marasà M, Kopp JB. Monoclonal antibodies for podocytopathies: rationale and clinical responses. Nat Rev Nephrol 2009: 5: 337.
83. Leroy S, Guigonis V, Bruckner D et al. Successful anti-TNF alpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant 2009: 9: 858.
84. Sugiyama S, Asano S, Tomita M et al. Focal segmental sclerotic lesions of the glomerulus in transplanted kidneys assessed using computerized image analysis. Clin Transplant 2003: 17(Suppl 10): 30.
85. Mizuiri S, Kawamura T, Miyagi M et al. Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis--angiotensin II immunostaining and treatment outcome. Clin Transplant 2005: 19(Suppl 14): 12.
86. Masutani K, Katafuchi R, Ikeda H et al. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases. Clin Transplant 2005: 19(Suppl 14): 59.
87. Yamamoto I, Yamamoto H, Mitome J et al. Secondary focal segmental glomerulosclerosis following kidney transplantation in a patient with type I diabetes mellitus. Clin Transplant 2006: 20(Suppl 15): 7.
88. Mitome J, Yamamoto H, Maruyama Y et al. Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation. Clin Transplant 2010: 24(Suppl 22): 48.
89. Ito Y, Nishi S, Imai N et al. Two distinct FSGS lesions caused by distinct etiology confirmed in a single patient in pre- and post-transplantation. Clin Transplant 2010: 24(Suppl 22): 54.
90. Sakai K, Takasu J, Nihei H et al. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient. Clin Transplant 2010: 24(Suppl 22): 60.